Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Grant

Showing results (181-190 of 386) with videos related to

Pageof 39
Sort By:
Cancer Research|December 18, 2012
Dual inhibition of Bcl-2 and Bcl-xL strikingly enhances PI3K inhibition-induced apoptosis in human myeloid leukemia cells through a GSK3- and Bim-dependent mechanismMohamed Rahmani, Mandy Mayo Aust, Elisa Attkisson, et al.
Blood|March 18, 2010
The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivoGirija Dasmahapatra, Dmitry Lembersky, Lora Kramer, et al.
Cancer Biology & Therapy|March 13, 2012
Sorafenib and HDAC inhibitors synergize to kill CNS tumor cellsYong Tang, Adly Yacoub, Hossein A Hamed, et al.
Molecular Cancer Therapeutics|March 29, 2013
The novel Chk1 inhibitor MK-8776 sensitizes human leukemia cells to HDAC inhibitors by targeting the intra-S checkpoint and DNA replication and repairYun Dai, Shuang Chen, Maciej Kmieciak, et al.
Blood|May 10, 2003
Synergistic antileukemic interactions between 17-AAG and UCN-01 involve interruption of RAF/MEK- and AKT-related pathwaysWentao Jia, Chunrong Yu, Mohamed Rahmani, et al.
Cancer Biology & Therapy|December 23, 2003
Sequence dependent exposure of mammary carcinoma cells to Taxotere and the MEK1/2 inhibitor U0126 causes enhanced cell killing in vitroAdly Yacoub, Song Iy Han, Ruben Caron, et al.
International Journal of Oncology|May 5, 2005
Modulation of sensitivity to doxorubicin by the histone deacetylase inhibitor sodium butyrate in breast cancer cellsMonette Louis, Roberto R Rosato, Eric Battaglia, et al.
Cancer Biology & Therapy|November 14, 2003
Induction of apoptosis in BCR/ABL+ cells by histone deacetylase inhibitors involves reciprocal effects on the RAF/MEK/ERK and JNK pathwaysChunrong Yu, Mark Subler, Mohamed Rahmani, et al.
British Journal of Haematology|March 8, 2011
Bortezomib interacts synergistically with belinostat in human acute myeloid leukaemia and acute lymphoblastic leukaemia cells in association with perturbations in NF-κB and BimYun Dai, Shuang Chen, Li Wang, et al.
Molecular Pharmacology|January 4, 2007
Conjugated bile acids regulate hepatocyte glycogen synthase activity in vitro and in vivo via Galphai signalingYouwen Fang, Elaine Studer, Clint Mitchell, et al.
Pageof 39

Showing results (181-190 of 386) with videos related to

Sort By:
Pageof 39
Cancer Research|December 18, 2012
Dual inhibition of Bcl-2 and Bcl-xL strikingly enhances PI3K inhibition-induced apoptosis in human myeloid leukemia cells through a GSK3- and Bim-dependent mechanismMohamed Rahmani, Mandy Mayo Aust, Elisa Attkisson, et al.
Blood|March 18, 2010
The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivoGirija Dasmahapatra, Dmitry Lembersky, Lora Kramer, et al.
Cancer Biology & Therapy|March 13, 2012
Sorafenib and HDAC inhibitors synergize to kill CNS tumor cellsYong Tang, Adly Yacoub, Hossein A Hamed, et al.
Molecular Cancer Therapeutics|March 29, 2013
The novel Chk1 inhibitor MK-8776 sensitizes human leukemia cells to HDAC inhibitors by targeting the intra-S checkpoint and DNA replication and repairYun Dai, Shuang Chen, Maciej Kmieciak, et al.
Blood|May 10, 2003
Synergistic antileukemic interactions between 17-AAG and UCN-01 involve interruption of RAF/MEK- and AKT-related pathwaysWentao Jia, Chunrong Yu, Mohamed Rahmani, et al.
Cancer Biology & Therapy|December 23, 2003
Sequence dependent exposure of mammary carcinoma cells to Taxotere and the MEK1/2 inhibitor U0126 causes enhanced cell killing in vitroAdly Yacoub, Song Iy Han, Ruben Caron, et al.
International Journal of Oncology|May 5, 2005
Modulation of sensitivity to doxorubicin by the histone deacetylase inhibitor sodium butyrate in breast cancer cellsMonette Louis, Roberto R Rosato, Eric Battaglia, et al.
Cancer Biology & Therapy|November 14, 2003
Induction of apoptosis in BCR/ABL+ cells by histone deacetylase inhibitors involves reciprocal effects on the RAF/MEK/ERK and JNK pathwaysChunrong Yu, Mark Subler, Mohamed Rahmani, et al.
British Journal of Haematology|March 8, 2011
Bortezomib interacts synergistically with belinostat in human acute myeloid leukaemia and acute lymphoblastic leukaemia cells in association with perturbations in NF-κB and BimYun Dai, Shuang Chen, Li Wang, et al.
Molecular Pharmacology|January 4, 2007
Conjugated bile acids regulate hepatocyte glycogen synthase activity in vitro and in vivo via Galphai signalingYouwen Fang, Elaine Studer, Clint Mitchell, et al.
Pageof 39